9783540434689 - chemosensitivity testing in oncology: 161 (recent results in cancer research, 161) de reinhold, u.; tilgen, w. (9 resultados)
Idioma: Inglés
Editorial: Springer, Germany 2003
Serie: Recent Results in Cancer Research, Libro 38 de 157. Libro 38 de 157 - Recent Results in Cancer Research
- Tapa dura
Librería: The Book Exchange, Macclesfield, CHESH, Reino UnidoThe Book Exchange
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Bueno
EUR 25,80
Envío por EUR 23,17Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: Very Good. 3540434682. Hardcover, from closed pharmaceutical company library, light corner wear. Lending record shows this book has never been borrowed. 255 pages, index, illustrated with charts, tables and diagrams. The clinical utility of drug response assays has been evaluated in clinical trials and the…results suggest that assay-assisted therapy selection may improve survival as well as economic outcomes. This volume comprises the proceedings of the first Symposium of the International Society for Chemosensitivity Testing in Oncology, ISCO-1, held in Homburg/Saar, Germany, in September 2001. Topics include: new in vitro drug-testing methods, tumor chemosensitivity assays, and the clinical relevance of assay-directed therapy. Contents clean, tight and bright. Book.
Idioma: Inglés
Editorial: Springer. 2002
Serie: Recent Results in Cancer Research, Libro 38 de 157. Libro 38 de 157 - Recent Results in Cancer Research
- Tapa dura
Librería: Universitätsbuchhandlung Herta Hold GmbH, Berlin, , AlemaniaUniversitätsbuchhandlung Herta Hold GmbH
Contactar con el vendedorVendedor de 4 estrellasCondición: Usado
EUR 35,00
Envío por EUR 30,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
2003th ed. 17 x 23 cm. 255 pages. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Idioma: Inglés
Editorial: Springer, J.B. Metzler 2002
Serie: Recent Results in Cancer Research, Libro 38 de 157. Libro 38 de 157 - Recent Results in Cancer Research
- Tapa dura
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 160,49
Envío por EUR 63,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past 50 years many in vitro and in vivo drug response assay systems have been developed to determine the potential - tivity of chemotherapy agents. The idea was to eliminate ineffective agents and unnecessary toxic treatment while selecting drugs… active in vitro or in the mouse model that might increase the probability of response in the patient. None of these test models, however, achieved routine clinical application in the past. This might be at least in part - lated to large discrepancies that were described between the s- cess rate of the assay systems and the clinical benefit in cancer - tients. The heterogeneity of chemosensitivity that exists between different tumors as well as between individual tumor lesions may be one explanation for these findings. Furthermore, different assay end points such as proliferation, metabolism, and vitality were - veloped to evaluate the effects of cytostatic drugs on tumor cells, and these might be related to the differing results. However, knowledge about procedures for assay-assisted treatment selection has increased rapidly within the past few years, and several studies suggest that test-directed chemotherapy selection now may - prove response rates and survival in various types of tumors. The International Society for Chemosensitivity Testing in - cology (ISCO) was founded to promote, coordinate, and improve clinical and laboratory research in the field of predictive drug te- ing in human tumor cells.
Idioma: Inglés
Editorial: Springer 2002
Serie: Recent Results in Cancer Research, Libro 38 de 157. Libro 38 de 157 - Recent Results in Cancer Research
- Tapa dura
Librería: Ria Christie Collections, Uxbridge, Reino UnidoRia Christie Collections
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 225,55
Envío por EUR 13,88Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New. In.
Idioma: Inglés
Editorial: Springer Verlag 2002
Serie: Recent Results in Cancer Research, Libro 38 de 157. Libro 38 de 157 - Recent Results in Cancer Research
- Tapa dura
Librería: Revaluation Books, Exeter, , Reino UnidoRevaluation Books
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 235,73
Envío por EUR 14,48Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Hardcover. Condición: Brand New. 1st edition. 245 pages. 9.25x6.50x0.50 inches. In Stock.
Idioma: Inglés
Editorial: Springer, J.B. Metzler Okt 2002 2002
Serie: Recent Results in Cancer Research, Libro 38 de 157. Libro 38 de 157 - Recent Results in Cancer Research
- Tapa dura
- Impresión bajo demanda
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, , AlemaniaBuchWeltWeit Ludwig Meier e.K.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 160,49
Envío por EUR 23,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Over the past 50 years many in vitro and in vivo drug response assay systems have been developed to determine the potential - tivity of chemotherapy agents. The idea was to eliminate ineffective agents and unnecessary toxic treatment while… selecting drugs active in vitro or in the mouse model that might increase the probability of response in the patient. None of these test models, however, achieved routine clinical application in the past. This might be at least in part - lated to large discrepancies that were described between the s- cess rate of the assay systems and the clinical benefit in cancer - tients. The heterogeneity of chemosensitivity that exists between different tumors as well as between individual tumor lesions may be one explanation for these findings. Furthermore, different assay end points such as proliferation, metabolism, and vitality were - veloped to evaluate the effects of cytostatic drugs on tumor cells, and these might be related to the differing results. However, knowledge about procedures for assay-assisted treatment selection has increased rapidly within the past few years, and several studies suggest that test-directed chemotherapy selection now may - prove response rates and survival in various types of tumors. The International Society for Chemosensitivity Testing in - cology (ISCO) was founded to promote, coordinate, and improve clinical and laboratory research in the field of predictive drug te- ing in human tumor cells. 256 pp. Englisch.
Idioma: Inglés
Editorial: Springer Berlin Heidelberg 2002
Serie: Recent Results in Cancer Research, Libro 38 de 157. Libro 38 de 157 - Recent Results in Cancer Research
- Tapa dura
- Impresión bajo demanda
Librería: moluna, Greven, , Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 136,16
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Over the past 50 years many in vitro and in vivo drug response assay systems have been developed to determine the potential - tivity of chemotherapy agents. The idea was to eliminate ineffective agents and unnecessary… toxic treatment while selecting drugs a.
Más imágenesIdioma: Inglés
Editorial: Springer 2002
Serie: Recent Results in Cancer Research, Libro 38 de 157. Libro 38 de 157 - Recent Results in Cancer Research
- Tapa dura
- Impresión bajo demanda
Librería: preigu, Osnabrück, Alemaniapreigu
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 141,20
Envío por EUR 70,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 5 disponibles
Buch. Condición: Neu. Chemosensitivity Testing in Oncology | Uwe Reinhold (u. a.) | Buch | x | Englisch | 2002 | Springer | EAN 9783540434689 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Idioma: Inglés
Editorial: Springer, J.B. Metzler Okt 2002 2002
Serie: Recent Results in Cancer Research, Libro 38 de 157. Libro 38 de 157 - Recent Results in Cancer Research
- Tapa dura
- Impresión bajo demanda
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 160,49
Envío por EUR 60,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Over the past 50 years many in vitro and in vivo drug response assay systems have been developed to determine the potential - tivity of chemotherapy agents. The idea was to eliminate ineffective agents and unnecessary toxic treatment while sel…ecting drugs active in vitro or in the mouse model that might increase the probability of response in the patient. None of these test models, however, achieved routine clinical application in the past. This might be at least in part - lated to large discrepancies that were described between the s- cess rate of the assay systems and the clinical benefit in cancer - tients. The heterogeneity of chemosensitivity that exists between different tumors as well as between individual tumor lesions may be one explanation for these findings. Furthermore, different assay end points such as proliferation, metabolism, and vitality were - veloped to evaluate the effects of cytostatic drugs on tumor cells, and these might be related to the differing results. However, knowledge about procedures for assay-assisted treatment selection has increased rapidly within the past few years, and several studies suggest that test-directed chemotherapy selection now may - prove response rates and survival in various types of tumors. The International Society for Chemosensitivity Testing in - cology (ISCO) was founded to promote, coordinate, and improve clinical and laboratory research in the field of predictive drug te- ing in human tumor cells.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 256 pp. Englisch.
